- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04770961
Erector Spinae Plane Block for Minimally Invasive Mitral Valve Surgery
March 1, 2021 updated by: University of California, San Francisco
Erector Spinae Plane Block for Minimally Invasive Mitral Surgery
The goal of this project is to study whether local anesthetic via the erector spinae plane (ESP) block may be beneficial in minimally invasive mitral valve surgery (MIMVS).
Study Overview
Status
Not yet recruiting
Detailed Description
This is a double blinded randomized controlled trial comparing a control group receiving cryoablation and sham block with an intervention group receiving cryoablation and ESP catheter.
The primary outcome is total oral morphine equivalent (OME) consumption within the first 48 hours of recovery including intra-operative usage.
Secondary outcomes to be evaluated would include pain scores, functional milestones like time to extubation, time to first PO intake, time to ambulation, time to chest tube removal, length of ICU and total hospital stay, complications, and patient satisfaction.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wilson Cui, MD, PhD
- Phone Number: 415-476-6783
- Email: wilson.cui@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
Contact:
- Wilson Cui, MD, PhD
- Phone Number: 415-476-6783
- Email: wilson.cui@ucsf.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 73 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elective mitral valve repair or replacement
- Planned minimally invasive approach
Exclusion Criteria:
- Non-English speaking
- Emergency surgery
- Planned or unplanned sternotomy
- Previous history of sternotomy and cardiac surgery
- Allergy to ropivacaine
- Patients taking more than 60 OMEs per day
- Patients with coagulopathy or taking anticoagulant with laboratory findings contraindicated for ESP catheter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Cryoablation
1. Cryoablation of intercostal nerves + Sham ESP catheter with saline infusion.
|
Ultrasound guided, right sided, ESP catheter inserted at the level of T5. 20 cc injection of saline is injected at the time of catheter placement.
Postoperatively, a programmed intermittent bolus infusion of saline will be delivered via the ESP catheter.
Other Names:
|
Experimental: ESP + Cryoablation
2. Cryoablation of intercostal nerves + ESP catheter with local anesthetic infusion.
|
Ultrasound guided, right sided, ESP catheter inserted at the level of T5. 20 cc injection of 0.5% Ropivacaine is injected at the time of catheter placement.
Postoperatively, a programmed intermittent bolus infusion of 0.2% Ropivacaine will be delivered via the ESP catheter.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total opiate consumption
Time Frame: 48 hours.
|
Total oral morphine equivalent (milligram) consumption within the first 48 hours of recovery including intra-operative usage, extracted from electronic medical record.
|
48 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain score
Time Frame: 48 hours
|
Pain Scores will be measured on the Visual Analog Scale (VAS), the score ranges from 0-10, zero indicating no pain and 10 indicating the worst pain, assessed by nursing staff, and extracted from electronic medical record.
|
48 hours
|
Time to extubation.
Time Frame: Within 30 days from end of operation.
|
Length from ICU arrival to endotracheal extubation (minutes).
If extubated in the operating room, the time will be 0 minute.
Extracted from electronic medical record.
|
Within 30 days from end of operation.
|
Time to first oral intake
Time Frame: Within 30 days from end of operation.
|
Length from ICU arrival to the time of first oral intake (hours).
Extracted from electronic medical record.
|
Within 30 days from end of operation.
|
Time to ambulation
Time Frame: Within 30 days from end of operation.
|
Length from ICU arrival to the time of first ambulation (hours).
Extracted from electronic medical record.
|
Within 30 days from end of operation.
|
Time to chest tube removal
Time Frame: Within 30 days from end of operation.
|
Length from ICU arrival to the time of last chest tube removal (hours).
Extracted from electronic medical record.
|
Within 30 days from end of operation.
|
Length of intensive care stay
Time Frame: Within 30 days from end of operation.
|
Length from ICU arrival to ICU discharge (hours).
Extracted from electronic medical record.
|
Within 30 days from end of operation.
|
Length of hospital stay
Time Frame: Within 30 days from end of operation.
|
Length from ICU arrival to hospital discharge (Hours).
Extracted from electronic medical record.
|
Within 30 days from end of operation.
|
Patient self-reported experience with surgery and postoperative recovery
Time Frame: 30 days after hospital discharge.
|
Based on questionnaires regarding the patient's experience with the efficacy of pain control and the satisfaction with postoperative recovery with scores from 1 (not satisfied at all) to 5 (very satisfied) conducted over telephone or video conferencing.
|
30 days after hospital discharge.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wilson Cui, MD, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2021
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
August 30, 2022
Study Registration Dates
First Submitted
February 22, 2021
First Submitted That Met QC Criteria
February 22, 2021
First Posted (Actual)
February 25, 2021
Study Record Updates
Last Update Posted (Actual)
March 3, 2021
Last Update Submitted That Met QC Criteria
March 1, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Heart Diseases
- Cardiovascular Diseases
- Pathological Conditions, Anatomical
- Heart Valve Diseases
- Heart Valve Prolapse
- Mitral Valve Insufficiency
- Prolapse
- Mitral Valve Prolapse
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anesthetics, Local
- Ropivacaine
Other Study ID Numbers
- 19-29298
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Regurgitation
-
Abbott Medical DevicesCompletedFunctional Mitral Regurgitation | Degenerrative Mitral RegurgitationRussian Federation
-
Ancora Heart, Inc.CompletedMitral Regurgitation | Mitral Valve Regurgitation | Functional Mitral RegurgitationAustria, Lithuania, Germany
-
Heinrich-Heine University, DuesseldorfCompletedMitral Regurgitation | Functional Mitral Regurgitation | Degenerative Mitral Valve RegurgitationGermany
-
Mitre Medical Corp.BSWRI Cardiac Imaging Core Lab (CICL)Not yet recruitingIschemic Mitral Regurgitation | Functional Mitral RegurgitationUnited States
-
Abbott Medical DevicesCompletedMitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With InsufficiencyJapan
-
Hospital Clinic of BarcelonaAbbottUnknownMITRAL REGURGITATIONSpain
-
Edwards LifesciencesRecruitingMitral Regurgitation | Mitral Insufficiency | Functional Mitral Regurgitation | Degenerative Mitral Valve DiseaseUnited States, Canada, Switzerland, Germany
-
Boston Scientific CorporationActive, not recruitingCardiovascular Diseases | Mitral Regurgitation Functional | Mitral Valve DiseaseUnited States, Australia
-
Abbott Medical DevicesActive, not recruitingHeart Failure | Mitral Regurgitation | Mitral Valve Regurgitation | Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure SubjectsUnited States, Canada
-
Mardil MedicalRecruitingFunctional Mitral RegurgitationCanada, Hungary, France, Germany, Netherlands, Panama, Poland
Clinical Trials on Erector spinae plane catheter with saline
-
Stanford UniversityNot yet recruitingAnesthesia, Local | Anesthesia | Microtia | Microtia, CongenitalUnited States
-
Soroka University Medical CenterUnknown
-
Security Forces HospitalNot yet recruitingOpioid Use | Post Operative PainSaudi Arabia
-
National Taiwan University HospitalRecruiting
-
University of California, San DiegoEnrolling by invitationRenal Stone | Pain, Acute PostoperativeUnited States
-
Ankara City Hospital BilkentCompletedErector Spinae Plane Block | Heart Rate | Mean Arterial Pressure | Video-Assisted Thoracoscopic SurgeryTurkey
-
Ben marzouk SofieneCompletedBreast Cancer Surgery | Postoperative AnalgesiaTunisia
-
Ain Shams UniversityRecruiting
-
University of California, San FranciscoRecruitingErector Spinae Plane Block | Lumbar Spine SurgeryUnited States
-
Assiut UniversityCompletedRenal Stone | Percutaneous | NephrolithotomyEgypt